Longitude Capital Partners III, LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Longitude Capital Partners III, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is a 10% Owner in Molecular Templates, Inc. ($MTEM) and a 10% Owner in Sierra Oncology, Inc. ($SRRA) and a 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and a 10% Owner in Inozyme Pharma, Inc. ($INZY) and a 10% Owner in 89bio, Inc. ($ETNB) and a 10% Owner in Talaris Therapeutics, Inc. ($TALS).
Address: 800 EL CAMINO, SUITE 220 MENLO PARK 94025 CA
Companies in which Longitude Capital Partners III, LLC is an Insider
89bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 2,600,877 shares
Latest Transaction: Jul 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Axonics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 2,400,000 shares
Latest Transaction: Nov 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 2,007,225 shares
Latest Transaction: Jul 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Molecular Templates, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 01 2020
$MTEM Market Capitalization: $41.30M
$MTEM Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sierra Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 1,477,320 shares
Latest Transaction: Jan 31 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Talaris Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 2,985,775 shares
Latest Transaction: May 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Longitude Capital Partners III, LLC
Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 406,338 | 0 | 0 | |
| May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,271,027 | 0 | 0 | |
| May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Option Exercise | C | 0.00 | 1,308,410 | 0 | 0 | |
| May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Buy | P | 17.00 | 235,000 | 3,995,000 | 3,220,775 | 3 M to 3.2 M (+7.87 %) |
| May 11 2021 | TALS | Talaris Therapeuti ... | Longitude Capital Partners III ... | 10% Owner | Buy | C | 0.00 | 2,985,775 | 0 | 2,985,775 | 0 to 3 M |
| Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 1,049 | 11,273 | 0 | 1 K to 0 (-100.00 %) |
| Sep 01 2020 | MTEM | Molecular Template ... | Longitude Capital Partners III ... | 10% Owner | Sell | S | 10.75 | 2,447 | 26,296 | 0 | 2.4 K to 0 (-100.00 %) |
View all Longitude Capital Partners III, LLC insider transactions.